Novonix Ltd. buy krebskrebs
Start price
22.02.21
/
50%
€2.42
Target price
22.02.22
€3.00
Performance (%)
39.59%
End price
23.02.22
€3.38
Summary
This prediction ended on 23.02.22 with a price of €3.38. The BUY prediction by krebskrebs for Novonix Ltd. saw massive gains of 39.59%. krebskrebs has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Novonix Ltd. | - | - | - | - |
iShares Core DAX® | 1.510% | 2.268% | 18.541% | 18.577% |
iShares Nasdaq 100 | -0.271% | -1.533% | 22.755% | 34.901% |
iShares Nikkei 225® | -0.108% | 0.411% | 10.352% | -0.876% |
iShares S&P 500 | 0.479% | 0.563% | 22.881% | 38.847% |
Comments by krebskrebs for this prediction
In the thread Novonix Ltd. diskutieren
Buy mit Kursziel 3,0
In the thread Trading Novonix Ltd.
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten